SPONSOR
Università Vita-Salute San Raffaele
Total Trials
3
Recruiting
3
Phases
Phase 4
Conditions studied: LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)Merosin Deficient CMD (Full or Partial)Merosin Deficient Congenital Muscular DystrophyAcute Respiratory FailureCardiac FailureLow Cardiac Output Syndrome
Università Vita-Salute San Raffaele is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A), LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\), Merosin Deficient CMD (Full or Partial), Merosin Deficient Congenital Muscular Dystrophy.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Università Vita-Salute San Raffaele
How many clinical trials has Università Vita-Salute San Raffaele sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Università Vita-Salute San Raffaele, of which 3 are actively recruiting participants. These trials cover conditions including LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A), LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\), Merosin Deficient CMD (Full or Partial). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Università Vita-Salute San Raffaele research focus on?
Università Vita-Salute San Raffaele clinical trials span LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A), LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\), Merosin Deficient CMD (Full or Partial), Merosin Deficient Congenital Muscular Dystrophy, Acute Respiratory Failure, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Università Vita-Salute San Raffaele clinical trial?
To participate in a Università Vita-Salute San Raffaele trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Università Vita-Salute San Raffaele trials with current recruitment status updated daily.
Clinical Trials by Università Vita-Salute San Raffaele
NCT07125040
Recruiting
Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers
LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
NCT01571986
Recruiting
Improving Non-invasive Ventilation
Acute Respiratory Failure
NCT06793670 Phase 4
Recruiting
Landiolol in Mitral Valve Surgery
Cardiac Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology